| Coagulation Panel |
|
Headline : None
Date : Wednesday, 28 October 2026
Start Time : 14:00
End Time : 17:00
Location : Aban
|
ChairSamaneh Salarvand |
|
Presentations |
|
14:00
|
Introduction, Panel Member Introductions, Importance Of Coagulation Tests In The Laboratory, & Presentation Of The First Scenario
Samaneh Salarvand |
|
14:10
|
Common Anticoagulant Drugs In Iran & Their Classification Based On Mechanism Of Action & Clinical Use
Keyhan Mohammadi |
|
14:20
|
Anticoagulant Drug Level Monitoring Tests: Indications & Associated Challenges
Keyhan Mohammadi |
|
14:35
|
The Impact Of Pre-analytical Variables On The Accuracy Of Coagulation Tests & Therapeutic Monitoring
Masoumeh Avarjeh |
|
14:50
|
Monitoring Therapy With PT, PTT: Key Points, Inter-Kit Differences, & Standardization Of Results
Samaneh Salarvand |
|
15:10
|
Clinical & Laboratory Approach To Heparin & Warfarin Resistance Cases, & Clinical Decision-Making
Keyhan Mohammadi |
|
15:25
|
Indications & Applications Of Monitoring With The Anti-Xa Test, Including Kit Differences & Interpretation Points
Samaneh Salarvand |
|
15:35
|
Role Of Point-of-Care Testing Methods In Evaluating & Monitoring Coagulation Tests
Mohammad Ali Boroumand |
|
|
|
15:50
|
Interpretation Of Coagulation Tests In Newborns & Young Children: Challenges, Indications, & Age-Dependent Reference Ranges
Masoumeh Avarjeh |
| Quality Assurance Panel (Part 1) |
|
Headline : None
Date : Friday, 30 October 2026
Start Time : 08:00
End Time : 10:30
Location : Mehr
|
ChairFarideh Razi |
|
Presentations |
|
|
|
|
|
|
|
|
|
|
